NanoVector's Grant

NanoVector raised a round of funding on January 12, 2009. Investors include National Science Foundation.

NanoVector is a pre-clinical stage therapeutic drug company developing the world's first commercially viable biologic nanoparticle-based therapeutic drug delivery system. The NanoVector breakthrough t…

Articles about NanoVector's Grant: